Week of September 25
9/28 Comment on cre-position-statement-on-kratom
CRE has conducted an in-depth review of the kratom issue and has read and benefited from the numerous comments posted on this website. Based on the said information, CRE has developed a proposal for addressing the issue.
We welcome public comments prior to arriving at a final position. Please note that the CRE position is contingent on the DEA not taking any additional action on its intent to ban kratom.
Comments can be posted at the bottom of this page. To this end see the insightful comments of Ms. Susan Ash filed at 2:02 PM September 28 below regarding actions by the DEA.
9/28 Regulation of kratom as a dietary supplement.
The following from the comments CRE received:
September 27, 2016 at 10:26 pm
9/27 Public Contact with the DEA
CRE received the following email from a reader; CRE has had a completely different experience when we contacted DEA. They were professional and helpful.
Good evening,I tried calling the DEA to please stop the ban on the wonderful herb Kratom. What I got was rudeness and they actually were laughing. They are unprofessional and they don’t care about the people. Many people will suffer and may die without Kratom. They laugh and think it’s funny. This is the same response they are giving with many people that are calling as well. Please. Please help stop the ban on Kratom. It would be a grave mistake to take it away from so many people.
9/27 Scientific American: Kratom Drug Ban May Cripple Promising Painkiller Research
By Angus Chen
. . .The ideal analgesic would not have the high risk of addiction, withdrawal or fatal respiratory slowdowns that have turned opioid abuse into a massive epidemic. The holy grail of painkillers would not induce the seductive euphoria of common opioids or their less-pleasant side effects like itching or constipation.
A painkiller with just one of these properties would be great, but Majumdar thinks he has stumbled onto a class of chemicals that might have them all. They are found in kratom, a plant that the U.S. Drug Enforcement Administration intends to effectively ban from the U.S. in an emergency move as early as September 30. Without legal access to it, research on some of the most promising leads for a better painkiller may grind to a crawl.
9/25 Bipartisan Support Against A Ban
In divided DC we seldom see both parties agree on anything. In this instance we note that influential members of Congress in both parties have opposed the kratom ban.
9/24 An Immediate Solution
The DEA states in its Federal Register Notice:
Additionally, this action is not a significant regulatory action as defined by Executive Order 12866 (Regulatory Planning and Review), section 3(f), and, accordingly, this action has not been reviewed by the Office of Management and Budget (OMB).
In its letter to the DEA, with a copy to OMB, CRE recommended that the “final order” be submitted to OMB because in fact it is a “significant regulatory action” because it changes the legal rights and obligations of a large number of Americans. (Ask any 1L law student who has taken administrative law.)
The immediate solution is to demand that DEA send the final order to OMB for review prior to publishing it in the federal register–in the alternative OMB can simply deem the kratom order to be a “significant regulatory action”–game over (at least for a while).
9/24 An Interesting Observation in Forbes Magazine
The following is from Forbes Magazine.
Note to readers: I’ve been reminded that the September 30 date may not necessarily be the effective date. Instead, it’s the earliest that DEA can issue its final order. As written under ‘Supplementary Information’ in the Notice of Intent in the Federal Register: “Any final order will be published in the Federal Register and may not be effective prior to September 30, 2016.” Therefore, sale and possession of kratom products may still be permitted after this date. I will update this post when the final order is published.
See Forbes Magazine Article.
9/24 To The Citizens Of Canada
We appreciate your continued efforts to encourage your government officials to educate their counterparts in the United States of the dire consequences of a US ban of katrom.
9/24 To a Reddit Author : Get A Life!
We note this post on Reddit made in response to a CRE post on this website.
Is this legit? Hard to trust something with such an obvious typo: “opiod”
CRE is a nationally recognized regulatory watchdog that has defended kratom with little financial support from the community and at a negative visibility cost to us and our traditional work. Defending kratom is hardly a popular cause.
Lack of financial support makes it difficult to assign staff for peer review to an account which is a financial loss. Check out our credentials. We welcome your calling attention to our typos but those of you who believe that counting the number of typos is a justifiable metric to assess to our legitimacy have a far greater problem then the DEA.
Fortunately the outpouring of support for CRE’s work dwarfs the views of a vocal minority, but it is time for some internal policing by the community in terms of how they address both the supporters and opponents of kratom.
Ad hominem attacks against established institutions, be they CRE or DEA, diminishes ones credibility. This website is one such forum for conducting the aforementioned self policing; CRE looks forward to seeing the results of such policing.
Week of September 18
Kratom Research Institute September 23, 2016 at 12:59 am
Canada currently regulates kratom as a legal Natural Health Product. Canada has seen no deaths or public health problems associated with having kratom legally available as a dietary supplement. Regulating kratom as a legal dietary supplement is the correct approach for the United States.
CRE is receiving reports that in some states that have kratom bans individuals are being incarcerated; CRE also has received, but has not confirmed, that in one of the aforementioned states that a very large chain of opioid treatment centers was behind the ban.